MIDD - Blog - A2-Ai

Leadership Blog Careers Get in touch

All posts Tag / MIDD

Tags

ADME AI animal testing approval process clinical pharmacology clinical trials cloud platform data analysis dose escalation drug development FDA IND

Simonne Bruck

Business Manager

MIDD - FDA Has Officially Announced Their Roadmap to Phase Out Animal Testing for Monoclonal Antibodies

Links

Home Leadership Careers Contact Blog

Pharmaceutical

FDA Project Optimus Preclinical Support Clinical Pharmacology Pharmacometrics Education

Technology

Overview A2-Ai Cloud

Resources

Community

LinkedIn GitHub RSS

A2-Ai is a premier full-service consultancy run by leaders who put science and patients first, with a focus on providing true value to our clients.

® A2-Ai LLC 2023

2723 S. State Street
Suite 310
Ann Arbor, MI 48104